Sinopharm To Buy Majority Stake In Aurobindo (Datong) Bio-Pharma
This article was originally published in PharmAsia News
Executive Summary
Indian generic drug maker Aurobindo Pharma recently announced that it had agreed to sell the majority stake of its Aurobindo (Datong) Bio-Pharma subsidiary in China, to Sinopharm, according to overseas media